Please enter your license information:
Patient Profiles
Identifying your Trajenta® patients.
-
Ria* 44 years oldNurse
Have you seen a patient like Ria?
-
Medical history
- T2DM since 2018
-
Physical characteristics
- Height: 5’ 4”
- Weight: 138 lbs
- BMI: 23.7 kg/m2
- BP: 116/73 mmHg
-
Notable laboratory results
- A1C: 7.9%
- FBG: 7.4 mmol/L
- Total cholesterol: 10.2 mmol/L
- HDL cholesterol: 4.1 mmol/L
- eGFR: 112 mL/min/1.73 m2
-
Clinic notes
- Works at a hospital
- Goes to the gym 2–3 days a week
- No co-morbidities
-
Current medications
- SYNJARDY® (12.5/500 mg BID)
Would you consider Trajenta® for patients like Ria?
-
-
Carlos* 59 years oldIT manager
Have you seen a patient like Carlos?
-
Medical history
- T2DM since 2014
- Coronary artery disease since 2019
- Chronic kidney disease since 2015
- Hypertension since 2016
-
Physical characteristics
- Height: 5’ 9”
- Weight: 165 lbs
- BMI: 24.4 kg/m2
- BP: 136/82 mmHg
-
Notable laboratory results
- A1C: 7.7%
- FBG: 8.4 mmol/L
- eGFR: 35 mL/min/1.73 m2
-
Clinic notes
- Visits his healthcare provider twice a year and his nurse every month to follow his T2DM
- Works long hours and has been trying to exercise more
- eGFR value is low
-
Current medications
- Metformin (1000 mg BID)
- JARDIANCE® (10 mg OD)
- Ramipril (10 mg OD)
Would you consider Trajenta® for patients like Carlos?
Trajenta® is not indicated for cardiovascular or renal outcomes.
-
-
Carol* 80 years oldVolunteer
Have you seen a patient like Carol?
-
Medical history
- T2DM since 2012
- Hypertension since 2009
- Mild kidney impairment since 2015
-
Physical characteristics
- Height: 5’ 9”
- Weight: 140 lbs
- BMI: 20.7 kg/m2
- BP: 131/79 mmHg
-
Notable laboratory results
- A1C: 8.2%
- FBG: 9.9 mmol/L
- eGFR: 70 mL/min/1.73 m2
-
Clinic notes
- Lives a healthy, active lifestyle and takes hour long walks almost daily
- Retired teacher who spends 3–4 days per week volunteering at a local soup kitchen
-
Current medications
- Metformin (1000 mg OD)
Would you consider Trajenta® for patients like Carol?
Trajenta® is not indicated for cardiovascular or renal outcomes.
-
Geriatrics (≥65 years of age): no dosage adjustment is required based on age, however, greater sensitivity in some older individuals cannot be ruled out.
A Trajenta® case study by Dr. Sivakumar MD, MPH, FRCPC.
Dr. Tharsan Sivakumar MD, MPH, FRCPC reviews a patient case and dosing information for Trajenta® and explains why Trajenta® may be a good option for your patients.
![](https://pro.boehringer-ingelheim.com/ca/products/trajenta/images/new-images/dr-sivakumar-thumbnail.png)
New video
BMI=body mass index; BP=blood pressure; FBG=fasting blood glucose; HDL=high-density lipoprotein; eGFR=estimated glomerular filtration rate; BID=twice daily; OD=once daily.
Fictitious patient. May not be representative of all patients.
Are you thinking Trajenta®?
![Healthcare professional and patient Healthcare professional and patient](https://pro.boehringer-ingelheim.com/ca/products/trajenta/images/login-banner-updated.png)
Are you a Canadian
View coverage details for Trajenta® and Jentadueto®
![Map of Canada Map of Canada](https://pro.boehringer-ingelheim.com/ca/products/trajenta/images/check-coverage-icon.png)